Forbes August 7, 2024
For over 30 years, Richard Pops has been the CEO of Alkermes (NASDAQ: ALKS), a company steadfastly focused on neuroscience—a notoriously challenging therapeutic area with highly stigmatized patient populations. When Pops joined Alkermes in 1991, it was a privately held company with only 25 employees. 32 years later, the company has more than 2,000 employees and is valued at nearly $4.3B. His journey from a 28-year old first-time CEO to leading the company through its public offering and numerous significant challenges, such as a 70% stock crash in 2002, is a testament to his resilience and vision. As a freshly minted CEO, Pops faced an important decision. Michael Wall, Alkermes’s founder, posed the question, do you want to build Alkermes...
Today's Sponsors
Today's Sponsor